SAN DIEGO, Aug. 29, 2012 -- MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for the treatment of cancer, announced today that Daniel P. Gold, Ph.D., President and Chief Executive Officer, will present an update on MEI Pharma and its lead oncology drug candidates, ME-143, ME-344 and Pracinostat, at the Stifel Nicolaus Healthcare Conference on Wednesday, September 5, 2012 at 3:50 p.m.
Eastern time from the Four Seasons Hotel in Boston. A live webcast of the presentation can be accessed at www.meipharma.com/investor. A replay will be available approximately one hour after the presentation.
PR Newswire